Humacyte Inc (HUMA)

Humacyte Inc (HUMA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $119M; returns 1 day +5.4%, 1 week +1.5%, 1 year -74.2%.

Humacyte Inc. (HUMA) is a biotechnology company focused on developing and manufacturing off-the-shelf, implantable, bioengineered human tissues. Their primary innovation lies in human acellular vessels (HAVs). Humacyte's mission is to revolutionize medicine by creating universally implantable bioengineered human tissues and organs.

Groups HUMA belongs to

• Biotechnology
• Medical Devices
• Biologics
• Regenerative Medicine
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Advanced Materials
• Organ Transplantation

HUMA financial model: income statement, cash flow and balance sheet